Pharming Group NV (PHARM) — Working Capital to Net Assets Ratio
Pharming Group NV (PHARM) has a Working Capital to Net Assets ratio of 71.7% as of September 2025. Working capital of €189.69 Million (current assets of €277.60 Million minus current liabilities of €87.91 Million) is measured against net assets of €264.64 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of Pharming Group NV to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Pharming Group NV Working Capital to Net Assets (2005–2024)
This chart shows how Pharming Group NV's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2005 to 2024. As of September 2025, the ratio stands at 71.7%, reflecting working capital of €189.69 Million against net assets of €264.64 Million EUR. For the complete balance sheet picture, see PHARM asset base.
Annual Working Capital to Net Assets for Pharming Group NV (2005–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Pharming Group NV from 2005 to 2024, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check PHARM financial resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 91.2% | €195.22 Million | €214.16 Million | €269.03 Million | €73.80 Million | ▼ -17.8 pp |
| 2023 | 109.0% | €215.79 Million | €198.05 Million | €286.37 Million | €70.58 Million | ▲ +2.5 pp |
| 2022 | 106.4% | €217.80 Million | €204.64 Million | €277.50 Million | €59.70 Million | ▲ +1.4 pp |
| 2021 | 105.1% | €202.46 Million | €192.72 Million | €249.18 Million | €46.72 Million | ▲ +3.5 pp |
| 2020 | 101.6% | €186.66 Million | €183.73 Million | €263.63 Million | €76.97 Million | ▲ +97.2 pp |
| 2019 | 4.4% | €5.17 Million | €117.26 Million | €119.30 Million | €114.13 Million | ▼ -48.8 pp |
| 2018 | 53.2% | €37.57 Million | €70.64 Million | €132.05 Million | €94.49 Million | ▼ -104.9 pp |
| 2017 | 158.1% | €35.66 Million | €22.56 Million | €105.87 Million | €70.22 Million | ▲ +118.7 pp |
| 2016 | 39.4% | €11.37 Million | €28.89 Million | €65.41 Million | €54.03 Million | ▼ -118.4 pp |
| 2015 | 157.8% | €41.13 Million | €26.06 Million | €55.86 Million | €14.73 Million | ▲ +43.0 pp |
| 2014 | 114.8% | €41.67 Million | €36.29 Million | €59.76 Million | €18.09 Million | ▼ -118.2 pp |
| 2013 | 233.0% | €16.12 Million | €6.92 Million | €33.97 Million | €17.85 Million | ▲ +226.2 pp |
| 2012 | 6.8% | €-686.38K | €-10.12 Million | €11.17 Million | €11.86 Million | ▲ +429.8 pp |
| 2011 | -423.1% | €6.51 Million | €-1.54 Million | €17.06 Million | €10.54 Million | ▼ -616.8 pp |
| 2010 | 193.7% | €26.02 Million | €13.43 Million | €38.90 Million | €12.88 Million | ▲ +251.5 pp |
| 2009 | -57.8% | €-11.03 Million | €19.07 Million | €40.93 Million | €51.97 Million | ▼ -244.7 pp |
| 2008 | 186.9% | €32.61 Million | €17.45 Million | €50.08 Million | €17.47 Million | ▲ +27.9 pp |
| 2007 | 159.0% | €80.41 Million | €50.58 Million | €114.75 Million | €34.33 Million | ▲ +92.4 pp |
| 2006 | 66.6% | €43.83 Million | €65.78 Million | €55.97 Million | €12.13 Million | ▼ -2.3 pp |
| 2005 | 68.9% | €23.46 Million | €34.04 Million | €30.22 Million | €6.76 Million | — |